Autori: Antonaci L

Filtra

Data

Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen

Nusinersen in pediatric and adult patients with type III spinal muscular atrophy

Clinical Variability in Spinal Muscular Atrophy Type III

Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey?

A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy

Long-term progression in type II spinal muscular atrophy: A retrospective observational study

Does albuterol have an effect on neuromuscular junction dysfunction in spinal muscular atrophy?

6MWT can identify type 3 SMA patients with neuromuscular junction dysfunction

Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy

Developmental milestones in type I spinal muscular atrophy

Torna in alto